| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260572.1 |
Tanespimycin |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033888517 |
Resistant |
| ENSG00000260572.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.007568032 |
Resistant |
| ENSG00000260572.1 |
Tanespimycin |
Brain lower grade glioma |
0.036275948 |
Resistant |
| ENSG00000260572.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.001071895 |
Resistant |
